ArticlePlant biotechnology journal2025
Field selection of elite events of East African highland bananas expressing elevated levels of pro-vitamin A.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pro-Vitamin A Biofortified Cavendish Banana: Trait Stability in the Field.Plant biotechnology journal · 2026Article
- Transgene-Free, Gene-Edited Cavendish Bananas (Musa acuminata, AAA).Plant biotechnology journal · 2026Article
- Effect of prolonged cooking on pro-vitamin A levels of biofortified East African highland bananas.GM crops & food · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Biofortification of staple crops is a sustainable strategy to deliver essential micronutrients to impoverished populations in developing countries. Banana is a highly valued crop consumed by over 75% of Ugandans. However, the starchy green cooking bananas have very low levels of pro-vitamin A (PVA) and heavy dietary reliance on them has been associated with vitamin A deficiency (VAD). Two banana cultivars, hybrid M9 and Nakitembe, were selected for PVA biofortification. A phytoene synthase 2a (MtPsy2a) gene was transformed into the selected cultivars under the control of the constitutive maize polyubiquitin1 promoter or the banana fruit-preferred ACC oxidase (ACO) promoter. Plants were regenerated on selective media and putatively transgenic plants confirmed by PCR. A total of 356 and 162 transgenic events for M9 and Nakitembe, respectively, were planted in a confined field trial (CFT). Transgenic plants were assessed against non-transformed controls. Selection was based on phenotype, cycle time, yield, β-carotene equivalents (β-CE) and transgene copy number. There were no significant variations in cycle time, but some phenotypic differences were observed between transgenic and non-transgenic controls. Transgenic fruits had yellow to orange fruit pulps, unlike pulp from non-transgenic controls that were paler. On average, fruit from transgenic M9 and Nakitembe accumulated fourfold and threefold more β-CE than non-transgenic controls, respectively. Five elite lines each of M9 and Nakitembe have been selected for national agronomic performance trials that will aid the selection of lead events to be considered for environmental release.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.